ABUS icon

Arbutus Biopharma
ABUS

Overview Fund Activity

51 hedge funds and large institutions have $81.7M invested in Arbutus Biopharma in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 13 closing their positions.

Holders
51
Holders Change
-4
Holders Change %
-7.27%
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
15
Reduced
17
Closed
13
Calls
$469K
Puts
$246K
Net Calls
+$223K
Net Calls Change
-$314K

Top Buyers

1
Bank of Montreal
1
Bank of Montreal
Ontario, Canada
$3.43M
2
SM
2
Sabby Management
Florida
$4.45M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.58M
4
SCM
4
Suffolk Capital Management
New York
$1.61M
5
Primecap Management
5
Primecap Management
California
$13M

Top Sellers

1
QF
1
QVT Financial
New York
$0
2
Franklin Resources
2
Franklin Resources
California
$5.73M
3
Citadel Advisors
3
Citadel Advisors
Florida
$1.2M
4
B
4
Bailard
California
$0
5
Millennium Management
5
Millennium Management
New York
$5.36M
Name Holding Trade Value Shares
Change 		Shares
Change %
SIA
51
Sit Investment Associates
Minnesota
– -$434K -71,200 Closed
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
– -$253K -41,482 Closed
KPF
53
K2 Principal Fund
Ontario, Canada
– -$226K -37,135 Closed
VAM
54
Visium Asset Management
New York
– -$193K -31,700 Closed
Jane Street
55
Jane Street
New York
– -$155K -25,374 Closed
AFM
56
Anson Funds Management
Texas
– -$152K -25,000 Closed
ARTA
57
A.R.T. Advisors
New York
– -$137K -22,617 Closed
NYLIM
58
New York Life Investment Management
New York
– -$60K -9,934 Closed
GXMC
59
Global X Management Company
New York
– -$31K -5,134 Closed
1 2
3